Insights On Outsourced Drug Development

  1. Advanced Therapies Going Mainstream: Are We There Yet? 11/14/2025

    Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.

  2. Evaluating CAR T-Cell Therapy Recruitment And Efficacy 4/17/2024

    Learn about Organ-on-a-Chip technology and how it can be employed to assess the efficacy of CAR T-cell therapies against solid tumors.

  3. A Simple Method For Cell Growth Media Preparation 11/3/2025

    Explore how powder media and sterile fluid handling can reduce contamination risk and improve efficiency in viral vector production, especially for HEK293-based AAV workflows.

  4. Role Of Chronic Inflammation In Risk For Neurodegenerative Disorders: Alzheimer's Disease 10/8/2024

    Explore how genetic and environmental risk factors interact to heighten Alzheimer's disease risk, and gain insight into a novel therapeutic approach.

  5. Enabling Quality By Design 9/8/2025

    Outdated quality systems delay product release. Discover how manufacturers can harness real-time data, operationalize QbD, and enhance compliance, efficiency, and supply chain continuity.

  6. API In Capsule Vs. The Lost Art Of Formulation Development 11/5/2025

    API-in-capsule offers a fast path for early clinical data, but it can't eliminate the need for full formulation development. Weighing the potential for higher total development time and cost is critical.

  7. Assessing Particle Generation In A Single-Use Mixing System 11/13/2025

    Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.

  8. Why Manual QbD Leads To Delays, Errors, And Ongoing Frustrations 10/24/2025

    Manual QbD methods slow timelines and increase risk. Learn how intelligent, digital frameworks are helping CMC teams improve quality, accelerate submissions, and meet rising regulatory expectations.

  9. A Universal Workflow Approach For Single Cell Mass Spectrometry Based Proteomics 11/7/2025

    Learn about a streamlined workflow that improves reproducibility, reduces contamination, and simplifies single-cell proteomics with comparable results to FACS.

  10. It's Never Too Late To Intensify: Upstream Process Intensification 9/21/2025

    Explore how early upstream intensification, flexible facility design, and smart technology choices can reduce costs, improve scalability, and support sustainability in low-volume protein therapy production.